Corient Private Wealth’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$382K Sell
1,425
-67,231
-98% -$19.4M ﹤0.01% 2181
2025
Q4
$1.13M Buy
68,656
+67,226
+4,701% +$21M ﹤0.01% 1820
2025
Q3
$401K Buy
1,430
+449
+46% +$122K ﹤0.01% 1938
2025
Q2
$237K Sell
981
-563
-36% -$133K ﹤0.01% 2127
2025
Q1
$376K Sell
1,544
-667
-30% -$201K ﹤0.01% 1738
2024
Q4
$726K Sell
2,211
-452
-17% -$153K ﹤0.01% 1448
2024
Q3
$891K Buy
2,663
+91
+4% +$28.9K ﹤0.01% 1453
2024
Q2
$702K Buy
2,572
+356
+16% +$104K ﹤0.01% 1471
2024
Q1
$766K Buy
2,216
+38
+2% +$12.5K ﹤0.01% 1426
2023
Q4
$703K Buy
2,178
+220
+11% +$69K ﹤0.01% 1437
2023
Q3
$702K Sell
1,958
-1,140
-37% -$440K ﹤0.01% 1320
2023
Q2
$1.17M Sell
3,098
-667
-18% -$271K ﹤0.01% 1093
2023
Q1
$1.81M Buy
3,765
+609
+19% +$285K ﹤0.01% 876
2022
Q4
$1.33M Buy
+3,156
New +$1.27M ﹤0.01% 826

Other funds holding BIO